Sandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in February

Sandoz Group AG (OTCMKTS:SDZNY) was the target of a large decrease in short interest in February. As of February 15th, there was short interest totalling 366,500 shares, a decrease of 52.6% from the January 31st total of 773,500 shares. Based on an average daily volume of 95,900 shares, the days-to-cover ratio is currently 3.8 days.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. UBS Group lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, February 3rd. BNP Paribas lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd.

Sandoz Group Price Performance

Shares of OTCMKTS:SDZNY traded down $0.30 during trading hours on Friday, hitting $43.80. The stock had a trading volume of 25,962 shares, compared to its average volume of 39,512. The stock’s fifty day simple moving average is $45.06 and its 200 day simple moving average is $43.93. Sandoz Group has a 1-year low of $27.79 and a 1-year high of $49.81.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.